Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
30 participants
INTERVENTIONAL
2023-03-07
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objective is to evaluate the impact of this rehabilitation protocol on functional outcome.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Potentiation of the Effects of Prismatic Adaptation by Transcranial Direct Current Stimulation (tDCS) : Evaluation of Functional Interest in Negligence Rehabilitation
NCT02213640
Improving Awareness for Spatial Neglect With tDCS
NCT04845529
Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study
NCT02935413
Effects of Prism Adaption and rTMS on Brain Connectivity and Visual Representation
NCT02911129
Immersive Virtual REality for Treatment of Unilateral Spatial NEglect Via Eye-tracking Biofeedback
NCT06264713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Patients will receive anodic tEs combined with prismatic lenses for two weeks
Prismatic adaptation and electric stimulation
Combinatory effect of tEs and prismatic lenses in the experimental group and of sham stimulation and prismatic lenses in control group
Control
Patients will receive sham tEs combined with prismatic lenses for two weeks
Prismatic adaptation and electric stimulation
Combinatory effect of tEs and prismatic lenses in the experimental group and of sham stimulation and prismatic lenses in control group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Prismatic adaptation and electric stimulation
Combinatory effect of tEs and prismatic lenses in the experimental group and of sham stimulation and prismatic lenses in control group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ischemic stroke
* hospitalization within 90 days of the event
Exclusion Criteria
* history of neurological disease
* history of psychiatric disease
* use of alchool and drugs
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Azienda USL Toscana Sud Est
OTHER_GOV
Istituti Clinici Scientifici Maugeri SpA
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Simona Spaccavento
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simona Spaccavento
Role: PRINCIPAL_INVESTIGATOR
Istituti Clinici Scientifici Maugeri
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituti Clinici Scientifici Maugeri
Bari, Ba, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Simona Spaccavento
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1183
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.